(Q44569179)

4 December 2017

title

Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis (English)

1 reference

4 December 2017

author name string

Barbara Kluve-Beckerman

1

1 reference

4 December 2017

Joyce Hardwick

2

1 reference

4 December 2017

Lijing Du

3

1 reference

4 December 2017

Merrill D Benson

4

1 reference

4 December 2017

Brett P Monia

5

1 reference

4 December 2017

Andrew Watt

6

1 reference

4 December 2017

Rosanne M Crooke

7

1 reference

4 December 2017

Adam Mullick

8

1 reference

4 December 2017

publication date

10 August 2011

1 reference

4 December 2017

1 reference

4 December 2017

volume

18

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

136-146

1 reference

Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Natural history and outcome in systemic AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Hereditary periodic fever and reactive amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Pathology, diagnosis and pathogenesis of AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive am

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Review. Reflections on amyloidosis in Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Eprodisate for the treatment of renal disease in AA amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Staining methods for identification of amyloid in tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Efficacy and safety of mipomersen, an antisense inhibitor of apolipoprotein B, in hypercholesterolemic subjects receiving stable statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13506129.2011.597464

10.3109/13506129.2011.597464

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference